Buy Trioday : Efavirenz, Lamivudine & Tenofovir Tablet 30’S Online

Description

1. Composition:

• Tenofovir Disoproxil Fumarate (Tenofovir DF): Tenofovir DF is a nucleotide reverse transcriptase inhibitor (NRTI) that inhibits the replication of the human immunodeficiency virus (HIV) by interfering with the viral enzyme reverse transcriptase. It is used in the treatment of HIV infection and acquired immunodeficiency syndrome (AIDS).
• Lamivudine: Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) that works by blocking the action of reverse transcriptase, an enzyme necessary for the replication of HIV. It is also used in the treatment of HIV infection and AIDS.
• Efavirenz: Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that inhibits the activity of reverse transcriptase, thereby preventing the replication of HIV. It is commonly used in combination with other antiretroviral drugs for the treatment of HIV infection.

2. Indications:

• HIV Infection: Trioday is indicated for the treatment of human immunodeficiency virus (HIV) type 1 infection in adults. It is used as part of combination antiretroviral therapy (ART) to suppress viral replication, improve immune function, and reduce the risk of disease progression.

3. Dosage and Administration:

• The recommended dosage of Trioday for adults is one tablet taken orally once daily, preferably on an empty stomach.
• The tablets should be swallowed whole with a glass of water and should not be crushed, chewed, or broken.
• Treatment with Trioday should be initiated by a healthcare professional experienced in the management of HIV infection, and dosage adjustments may be necessary based on individual patient factors and treatment response.

4. Effectiveness:

• Trioday has been shown to be highly effective in suppressing viral replication and improving immune function in patients with HIV infection.
• Clinical studies have demonstrated that combination therapy with tenofovir DF, lamivudine, and efavirenz can lead to significant reductions in HIV viral load and increases in CD4 cell counts, resulting in improved clinical outcomes and quality of life.

5. Safety Profile:

• Trioday is generally well-tolerated when used as prescribed. Common side effects may include headache, dizziness, nausea, vomiting, diarrhea, fatigue, and rash.
• Serious side effects such as liver toxicity, lactic acidosis, and immune reconstitution syndrome may occur but are rare.
• Patients should be monitored regularly for signs of adverse reactions, including liver function tests, renal function tests, and blood cell counts.

6. Contraindications:

• Trioday is contraindicated in patients with a known hypersensitivity to any of the active ingredients or excipients in the formulation.
• It should not be used in patients with severe liver impairment or in combination with certain medications that may interact with efavirenz.

7. Precautions:

• Trioday should be used with caution in patients with a history of psychiatric disorders, as well as in pregnant or breastfeeding women.
• It should be avoided in patients with a history of drug abuse or dependence, as well as in patients with a predisposition to developing renal impairment.

8. Storage:

• Trioday tablets should be stored at room temperature (15°C to 30°C) in a dry place, away from moisture and heat.
• Keep the medication out of reach of children and pets.

Trioday tablets, containing tenofovir DF, lamivudine, and efavirenz, provide a convenient and effective treatment option for patients with HIV infection. Treatment should be initiated and supervised by a qualified healthcare professional, and patients should be closely monitored for both efficacy and safety throughout the treatment course.